Expertise in
10
conditions

Ronan Roussel

Paris, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
10
conditions
Paris, FR 
OverviewLocationsClinical Research

Overview

Ronan Roussel practices in Paris, France. Mr. Roussel is highly rated in 10 conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Diabetic Nephropathy, Low Blood Sugar, Percutaneous Coronary Intervention (PCI), and Kidney Transplant.

His clinical research consists of co-authoring 211 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Paris, France
Other Locations
France
Rennes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Observational Study of the Use of DBLG1 System in Real Life
Observational Study of the Use of DBLG1 System in Real Life
Enrollment Status: Recruiting
Publish Date: May 07, 2024
Intervention Type: Device
A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control
A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control
Enrollment Status: Suspended
Publish Date: November 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Enrollment Status: Terminated
Publish Date: April 09, 2025
Intervention Type: Other
Study Phase: Not Applicable
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)
The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France (EQOL Study)
Enrollment Status: Completed
Publish Date: July 08, 2024
Intervention Type: Device
Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
Enrollment Status: Unknown
Publish Date: April 14, 2023
Intervention Type: Drug
Study Drug: Liraglutide
Study Phase: Phase 2
Interventional Multi-Center Post Market Randomized Controlled Open-Label Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Hard to Heal Diabetic Foot Wounds
Interventional Multi-Center Post Market Randomized Controlled Open-Label Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Hard to Heal Diabetic Foot Wounds
Enrollment Status: Completed
Publish Date: February 10, 2023
Intervention Type: Device
Study Phase: Not Applicable
Withings Study to Analyse the Accuracy of Screening Small Fiver Neuropathy With a Bathroom Scale
Withings Study to Analyse the Accuracy of Screening Small Fiver Neuropathy With a Bathroom Scale
Enrollment Status: Completed
Publish Date: January 25, 2023
Intervention Type: Diagnostic test
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Enrollment Status: Completed
Publish Date: August 21, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

211 Total Publications

Electrochemical skin conductance: a tool for risk stratification and early anticipation of diabetic foot ulcers.
Electrochemical skin conductance: a tool for risk stratification and early anticipation of diabetic foot ulcers.
Journal: Frontiers in endocrinology
Published: May 31, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Roussel's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile